TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)
TELA Bio (TELA) posted Cash from Financing Activities of -$15000.0 for Q2 2026, up 94.97% on a QoQ basis from -$298000.0 in Q1 2026, and down 400.0% year-over-year from $5000.0 in Q2 2025.
Powered by 
Analysis
TELA Bio (TELA) Cash from Financing Activities (2018 - 2026) Analysis & Trends
TELA Bio has reported Cash from Financing Activities for 9 years, with the latest figure at -$15000.0 in Q2 2026.
- On a quarterly basis, Cash from Financing Activities fell 400.0% year-over-year to -$15000.0 in Q2 2026; TTM through Jun 2026 was $25.6 million, a 40.41% decrease from a year earlier, with the FY2025 full-year figure at $25.8 million, down 40.2% from the prior year.
- Cash from Financing Activities was -$15000.0 for Q2 2026 at TELA Bio, up from -$298000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $46.4 million in Q2 2023, with the low at -$298000.0 in Q1 2026.
- Average Cash from Financing Activities over 5 years is $8.6 million, with a median of $23000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities sank 505.56% in 2022, then soared 194936.36% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$219000.0 in 2022, then soared by 110.05% to $22000.0 in 2023, then jumped by 194936.36% to $42.9 million in 2024, then plunged by 39.77% to $25.8 million in 2025, then slumped by 100.06% to -$15000.0 in 2026.
- The last three Cash from Financing Activities figures came in at -$15000.0 (Q2 2026), -$298000.0 (Q1 2026), and $25.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 127.72 Bn | 122.50 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 116.88 Bn | 108.06 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 104.10 Bn | 100.62 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 63.74 Bn | 63.20 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 49.85 Bn | 45.60 Bn | 1.35 Bn | -300,000.00 |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | -510.00 Mn |
| 8 | Dexcom | 32.15 Bn | 30.20 Bn | 830.00 Mn | -607.30 Mn |
| 9 | Steris | 20.63 Bn | 20.15 Bn | 684.20 Mn | -213.50 Mn |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn | -15,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,000.00 |
| Mar 31, 2026 | -298,000.00 |
| Dec 31, 2025 | 25.85 Mn |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -116,000.00 |
| Dec 31, 2024 | 42.91 Mn |
| Sep 30, 2024 | 98,000.00 |
| Jun 30, 2024 | -5,000.00 |
| Mar 31, 2024 | 56,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 71,000.00 |
| Jun 30, 2023 | 46.41 Mn |
| Mar 31, 2023 | -235,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | 34.57 Mn |
| Jun 30, 2022 | 6.65 Mn |
| Mar 31, 2022 | -146,000.00 |
| Dec 31, 2021 | 174,000.00 |
| Sep 30, 2021 | 259,000.00 |